InvestorsHub Logo
Followers 4
Posts 217
Boards Moderated 0
Alias Born 03/18/2015

Re: None

Friday, 02/10/2017 9:27:41 AM

Friday, February 10, 2017 9:27:41 AM

Post# of 130502
Not to say their isn't value in the quite extensive diagnostics IP/Avant interest, that's yet to be determined. Same with the Theranostics. I am curious to see how that develops. ESS maybe. Let's see if anything happens. But MANF is the real bread and butter to develop...if only AMBS could get it into human trials. Optimistic a solution emerges.